Perrigo
This article was originally published in The Tan Sheet
Executive Summary
Wrafton Labs acquisition complete, private labeler announces June 29. Perrigo reached agreement to buy UK-based Wrafton on June 1 for $44 mil. (1"The Tan Sheet" June 4, p. 7)
You may also be interested in...
Perrigo Famotidine Approved With Six Month Exclusivity; Shipments Begin
Perrigo's private label famotidine 10 mg was approved by FDA May 31, ending a drawn out delay of the generic launch.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands